← Back to headlines
Axsome Therapeutics CEO Sells $6 Million in Options Ahead of FDA Decision
The CEO of Axsome Therapeutics has completed a planned sale of $6 million in company options, a move made ahead of a crucial FDA decision regarding the company's products.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Oil Prices Rise After Previous Day's Sharp Drop
just now
US and Iran Reportedly Deadlocked Over Hormuz Strait Customs Dispute
48m ago
Expert Questions Significance of France's Credit Rating Amid Lower Borrowing Costs for Italy and Spain
2h ago
Homeowners Over 50 Can Save Thousands Annually with Overlooked Tax Breaks
2h ago